Cardiorenal Syndrome clinical trials at UCSF

1 research study open to eligible people

Cardiorenal syndrome is when heart and kidney problems happen together. UCSF is testing if a new device, Aortix, can help people with severe heart failure who are hospitalized. Another study is comparing diuretics alone to this device to see which works better in severe cases.

Showing trials for

  • Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

    open to eligible people ages 21 years and up

    Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) and have persistent congestion despite usual medical therapy. Eligible ADHF patients with diuretic resistance (irrespective of ejection fraction) will be enrolled and randomized 1:1 to either the Aortix system or standard of care medical management.

    San Francisco, California and other locations

Our lead scientists for Cardiorenal Syndrome research studies include .

Last updated: